Ascendis Pharma Dividend
Dividend criteria checks 0/6
Ascendis Pharma does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.9% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$8.43 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Some Confidence Is Lacking In Ascendis Pharma A/S' (NASDAQ:ASND) P/S
Apr 05
Ascendis Pharma's Ambitious Vision 2030
Jan 11What Ascendis Pharma A/S' (NASDAQ:ASND) 29% Share Price Gain Is Not Telling You
Dec 21Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?
Nov 10Ascendis Pharma A/S' (NASDAQ:ASND) Popularity With Investors Is Under Threat From Overpricing
Oct 05Is Ascendis Pharma (NASDAQ:ASND) Using Debt Sensibly?
Jun 27Analysts Are Betting On Ascendis Pharma A/S (NASDAQ:ASND) With A Big Upgrade This Week
May 05Is Ascendis Pharma (NASDAQ:ASND) Using Debt In A Risky Way?
Feb 18Is Ascendis Pharma (NASDAQ:ASND) A Risky Investment?
Sep 24Ascendis Pharma: TransCon CNP Data Coming Q4
Sep 15Ascendis Pharma seeks FDA nod for its parathyroid hormone restorer TransCon PTH
Aug 31Ascendis Pharma Q2 results beat buoyed by strong sales of growth hormone drug Skytrofa
Aug 11Ascendis Pharma: Institutional Buying Values Dutch Biotech Best-Now Cap-Gain Prospect
Aug 03Here's Why Ascendis Pharma (NASDAQ:ASND) Can Manage Its Debt Despite Losing Money
Jun 10Ascendis Pharma: Biotech Bear Provides Attractive Entry Point
May 09Ascendis: Institutional Buying Activity Now Seen As Good Value By Market-Makers
Apr 29Ascendis Pharma A/S' (NASDAQ:ASND) Intrinsic Value Is Potentially 51% Above Its Share Price
Feb 24Is Ascendis Pharma (NASDAQ:ASND) In A Good Position To Invest In Growth?
Jan 07Ascendis: Danish Biotech With Thin Audience Now Seen As Good Value By Market-Makers
Dec 30Ascendis Pharma A/S' (NASDAQ:ASND) Intrinsic Value Is Potentially 97% Above Its Share Price
Sep 24Ascendis Pharma: A Promising Platform And A Rich Valuation
Sep 10We're Hopeful That Ascendis Pharma (NASDAQ:ASND) Will Use Its Cash Wisely
Aug 12Best Biotech Stock (Now): Ascendis Pharma, Where Best = Capital Gain ODDS Next 3 Months
Jun 30Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if ASND's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ASND's dividend payments have been increasing.
Dividend Yield vs Market
| Ascendis Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (ASND) | n/a |
| Market Bottom 25% (US) | 1.6% |
| Market Top 25% (US) | 4.8% |
| Industry Average (Biotechs) | 2.9% |
| Analyst forecast in 3 Years (ASND) | 0% |
Notable Dividend: Unable to evaluate ASND's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ASND's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate ASND's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as ASND has not reported any payouts.